Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased index when they act together with antisera to the V3 neutralization epitopeDAVIS, D; STEPHENS, D. M; CARNE, C. A et al.Journal of general virology. 1993, Vol 74, pp 2609-2617, issn 0022-1317, 12Article

Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotypeFOUCHIER, R. A. M; BROERSEN, S. M; BROUWER, M et al.AIDS research and human retroviruses. 1995, Vol 11, Num 12, pp 1473-1478, issn 0889-2229Article

Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loopYOSHIYAMA, H; HONGMEI MO; MOORE, J. P et al.Journal of virology. 1994, Vol 68, Num 2, pp 974-978, issn 0022-538XArticle

Relationship of HIV-1 envelope V2 and V3 sequences of the primary isolates to the viral phenotypeYOSHIMURA, K; MATSUSHITA, S; HAYASHI, A et al.Microbiology and immunology. 1996, Vol 40, Num 4, pp 277-287, issn 0385-5600Article

Relation of phenotype evolution of HIV-1 to envelope V2 configurationGROENINK, M; FOUCHIER, R. A. M; BROERSEN, S et al.Science (Washington, D.C.). 1993, Vol 260, Num 5113, pp 1513-1516, issn 0036-8075Article

A novel, glycan-dependent epitipe in the V2 domain of human immunodeficiency virus type 1 gp 120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibodyWARRIER, S. V; PINTER, A; HONNEN, W. J et al.Journal of virology. 1994, Vol 68, Num 7, pp 4636-4642, issn 0022-538XArticle

Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120FUNG, M. S. C; SUN, C. R. Y; GORDON, W. L et al.Journal of virology. 1992, Vol 66, Num 2, pp 848-856, issn 0022-538XArticle

HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressorsBIN WANG; SPIRA, T. J; OWEN, S et al.AIDS (London). 2000, Vol 14, Num 3, pp 213-223, issn 0269-9370Article

Envelope V2 configuration and HIV-1 phenotype : clarificationSCHUITEMAKER, H; FOUCHIER, R. A. M; BROERSEN, S et al.Science (Washington, D.C.). 1995, Vol 268, Num 5207, issn 0036-8075, p. 115Article

Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formationANDEWEG, A. C; LEEFLANG, P; OSTERHAUS, A. D. M. E et al.Journal of virology. 1993, Vol 67, Num 6, pp 3232-3239, issn 0022-538XArticle

Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replicationSTAMATATOS, L; WISKERCHEN, M; CHENG-MAYER, C et al.AIDS research and human retroviruses. 1998, Vol 14, Num 13, pp 1129-1139, issn 0889-2229Article

The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropismMORIKITA, T; MAEDA, Y; FUJII, S.-I et al.AIDS research and human retroviruses. 1997, Vol 13, Num 15, pp 1291-1299, issn 0889-2229Article

Sequence analysis of the V1/V2 and V3 domains in an HIV-seronegative AIDS patientVALLEJO, A; BRAVO, R; HEREDIA, A et al.AIDS research and human retroviruses. 1995, Vol 11, Num 12, pp 1539-1541, issn 0889-2229Article

Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies : human immune response to the V1 and V2 domainsMOORE, J. P; SATTENTAU, Q. J; ROBEY, G et al.Journal of virology. 1993, Vol 67, Num 10, pp 6136-6151, issn 0022-538XArticle